These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3883743)

  • 1. Optimum effectiveness of intestinal alpha-glucosidase inhibitors: importance of uniform distribution through a meal.
    O'Dea K; Turton J
    Am J Clin Nutr; 1985 Mar; 41(3):511-6. PubMed ID: 3883743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scope and specificity of acarbose in slowing carbohydrate absorption in man.
    Jenkins DJ; Taylor RH; Goff DV; Fielden H; Misiewicz JJ; Sarson DL; Bloom SR; Alberti KG
    Diabetes; 1981 Nov; 30(11):951-4. PubMed ID: 7028548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and short term effects of intestinal alpha-glucosidase inhibition on gut hormone responses in man.
    Uttenthal LO; Ukponmwan OO; Ghiglione M; Bloom SR
    Dig Dis Sci; 1987 Feb; 32(2):139-44. PubMed ID: 3542445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method.
    Radziuk J; Kemmer F; Morishima T; Berchtold P; Vranic M
    Diabetes; 1984 Mar; 33(3):207-13. PubMed ID: 6365657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined use of guar and acarbose in reduction of postprandial glycaemia.
    Jenkins DJ; Taylor RH; Nineham R; Goff DV; Bloom SR; Sarson D; Alberti KG
    Lancet; 1979 Nov; 2(8149):924-7. PubMed ID: 91023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-Glucosidase inhibition improves postprandial hyperglycemia and decreases insulin requirements in insulin-dependent diabetes mellitus.
    Dimitriadis GD; Tessari P; Go VL; Gerich JE
    Metabolism; 1985 Mar; 34(3):261-5. PubMed ID: 3883097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose.
    Fölsch UR; Ebert R; Creutzfeldt W
    Scand J Gastroenterol; 1981; 16(5):629-32. PubMed ID: 7034156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of disaccharide digestion in rat intestine by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
    Krause HP; Keup U; Puls W
    Digestion; 1982; 23(4):232-8. PubMed ID: 6754513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manipulation of gut hormone response to food by soluble fiber and alpha-glucosidase inhibition.
    Jenkins DJ; Taylor RH; Nineham R; Goff DV; Bloom SR; Sarson DL; Misiewicz JJ; Alberti KG
    Am J Gastroenterol; 1988 Apr; 83(4):393-7. PubMed ID: 2831707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fate and effects of the alpha-glucosidase inhibitor acarbose in humans. An intestinal slow-marker perfusion study.
    Ruppin H; Hagel J; Feuerbach W; Schutt H; Pichl J; Hillebrand I; Bloom S; Domschke W
    Gastroenterology; 1988 Jul; 95(1):93-9. PubMed ID: 3286363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: dose-time-response relationships in man.
    Hillebrand I; Boehme K; Frank G; Fink H; Berchtold P
    Res Exp Med (Berl); 1979 Apr; 175(1):87-94. PubMed ID: 375343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the disaccharidase inhibitor acarbose on meal and intravenous glucose tolerance in normal man.
    Dimitriadis G; Tessari P; Go V; Gerich J
    Metabolism; 1982 Aug; 31(8):841-3. PubMed ID: 7047984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man.
    Hillebrand I; Boehme K; Frank G; Fink H; Berchtold P
    Res Exp Med (Berl); 1979 Apr; 175(1):81-6. PubMed ID: 375342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acarbose on starch hydrolysis. Study in healthy subjects, ileostomy patients, and in vitro.
    Hiele M; Ghoos Y; Rutgeerts P; Vantrappen G
    Dig Dis Sci; 1992 Jul; 37(7):1057-64. PubMed ID: 1618053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptation of the small intestine to induced maldigestion in rats. Experimental pancreatic atrophy and acarbose feeding.
    Creutzfeldt W; Fölsch UR; Elsenhans B; Ballmann M; Conlon JM
    Scand J Gastroenterol Suppl; 1985; 112():45-53. PubMed ID: 3892654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release.
    Enç FY; Imeryüz N; Akin L; Turoğlu T; Dede F; Haklar G; Tekeşin N; Bekiroğlu N; Yeğen BC; Rehfeld JF; Holst JJ; Ulusoy NB
    Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G752-63. PubMed ID: 11518688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of sucrose- and starch-induced glycaemic and hormonal responses by the alpha-glucosidase inhibitor emiglitate (BAY o 1248) in healthy volunteers.
    Lembcke B; Fölsch UR; Gatzemeier W; Lücke B; Ebert R; Siegel E; Creutzfeldt W
    Eur J Clin Pharmacol; 1991; 41(6):561-7. PubMed ID: 1815967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus.
    Santeusanio F; Compagnucci P
    Drug Saf; 1994 Dec; 11(6):432-44. PubMed ID: 7727053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of physical form of carbohydrate on the postprandial glucose, insulin, and gastric inhibitory polypeptide responses in type 2 diabetes.
    Collier G; O'Dea K
    Am J Clin Nutr; 1982 Jul; 36(1):10-4. PubMed ID: 7046411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of metabolic control in insulin dependent diabetics treated with the alpha-glucosidase inhibitor acarbose for two months.
    Gérard J; Luyckx AS; Lefebvre PJ
    Diabetologia; 1981 Nov; 21(5):446-51. PubMed ID: 7028558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.